PMID- 28286103 OWN - NLM STAT- MEDLINE DCOM- 20170824 LR - 20170824 IS - 1872-7573 (Electronic) IS - 0378-8741 (Linking) VI - 202 DP - 2017 Apr 18 TI - The vascular protective effects of Anoectochilus roxburghii polysaccharose under high glucose conditions. PG - 192-199 LID - S0378-8741(16)30852-2 [pii] LID - 10.1016/j.jep.2017.03.012 [doi] AB - ETHNOPHARMACOLOGICAL RELEVANCE: Anoectochilus roxburghii has been used as a health food and a herb for treatment diabetes in China for hundreds years. Anoectochilus roxburghii polysaccharose (ARP) is the major active component of the plant. AIM OF THE STUDY: The present study investigated the vascular protection of ARP in vivo and in vitro experiments. MATERIALS AND METHODS: Hypoglycemic activity of ARP was examined in diabetic mice. Moreover, the further vascular protective effects in vitro were investigated in human umbilical vein endothelial cells (HUVECs) stimulated by high glucose (HG, 35mM). RESULTS: Compared with untreated diabetic mice, ARP (100 or 300mg/kg) caused a significant decrease in blood glucose levels. Histological examination showed that ARP ameliorated endothelial damage to some extent, especially ARP at dosage of 300mg/kg. In vitro assay, pretreatment with ARP (10, 20 and 30mug/mL) markedly inhibited generations of reactive oxygen species (ROS), monocyte chemoattractant protein-1 (MCP-1) and intercellular adhesion molecule-1 (ICAM-1) in HG-induced HUVECs. ARP pretreatment not only suppressed HG-induced matrix metalloproteinases (MMPs) activity via increasing the expression of the tissue inhibitors of MMPs (TIMPs), but also adjusted the MMPs/TIMPs balance to maintain homeostasis of vascular structure. Moreover, pretreatment with ARP could significantly reduce p-NF-kappaB p65, p-p38 MAPK expression levels in HG-induced HUVECs. CONCLUSIONS: The vascular protective effects of ARP might be associated with NF-kappaB and p38 MAPK pathway. ARP might be used as useful substance in the treatment of vasculopathy in diabetic patients. CI - Copyright (c) 2017 Elsevier Ireland Ltd. All rights reserved. FAU - Liu, Zhen-Ling AU - Liu ZL AD - State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, PR China. Electronic address: liuzhl@lzu.edu.cn. FAU - Zhang, Jian-Gang AU - Zhang JG AD - Institute of pathology, Lanzhou university, Lanzhou 730000, PR China. FAU - Liu, Qing AU - Liu Q AD - Department of Chemical and Pharmaceutical Engineering, College of Chemical Engineering, Huaqiao University, Xiamen 361021, Fujian province, PR China. FAU - Yi, Li-Tao AU - Yi LT AD - Department of Chemical and Pharmaceutical Engineering, College of Chemical Engineering, Huaqiao University, Xiamen 361021, Fujian province, PR China. FAU - Li, Yu-Meng AU - Li YM AD - Department of Chemical and Pharmaceutical Engineering, College of Chemical Engineering, Huaqiao University, Xiamen 361021, Fujian province, PR China. FAU - Li, Ya AU - Li Y AD - State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, PR China. LA - eng PT - Journal Article DEP - 20170310 PL - Ireland TA - J Ethnopharmacol JT - Journal of ethnopharmacology JID - 7903310 RN - 0 (Antioxidants) RN - 0 (Blood Glucose) RN - 0 (Cytokines) RN - 0 (Hypoglycemic Agents) RN - 0 (Polysaccharides) SB - IM MH - Animals MH - Antioxidants/pharmacology MH - Aorta, Thoracic/drug effects MH - Blood Glucose/metabolism MH - Cytokines/biosynthesis MH - Diabetes Mellitus, Experimental/drug therapy MH - Diabetic Angiopathies/pathology/*prevention & control MH - Human Umbilical Vein Endothelial Cells MH - Humans MH - Hypoglycemic Agents/*pharmacology MH - Male MH - Medicine, Chinese Traditional MH - Mice MH - Mice, Inbred ICR MH - Orchidaceae/*chemistry MH - Polysaccharides/chemistry/*pharmacology MH - Signal Transduction/drug effects OTO - NOTNLM OT - Anoectochilus roxburghii OT - NF-kappaB OT - P38 MAPK OT - Polysaccharose OT - Vascular protection EDAT- 2017/03/14 06:00 MHDA- 2017/08/25 06:00 CRDT- 2017/03/14 06:00 PHST- 2016/09/15 00:00 [received] PHST- 2017/01/21 00:00 [revised] PHST- 2017/03/09 00:00 [accepted] PHST- 2017/03/14 06:00 [pubmed] PHST- 2017/08/25 06:00 [medline] PHST- 2017/03/14 06:00 [entrez] AID - S0378-8741(16)30852-2 [pii] AID - 10.1016/j.jep.2017.03.012 [doi] PST - ppublish SO - J Ethnopharmacol. 2017 Apr 18;202:192-199. doi: 10.1016/j.jep.2017.03.012. Epub 2017 Mar 10.